DIVISIONS

The Westaim Corporation invests in high-potential businesses targeting large commercial markets. Its two technology investments, iFire Technology and NUCRYST Pharmaceuticals, aim to be significant players in their respective fields.



iFire Technology has patented a developmental low-cost, high-performance flat panel technology called thick dielectric electroluminescent (TDEL).



NUCRYST Pharmaceuticals researches, develops and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology.